TMCnet News
Human Vaccines Market 2017: Global Industry Analysis, Trends, Market Size & Forecasts to 2023 - Research and MarketsThe "Human Vaccines Market: Global Industry Analysis, Trends, Market Size & Forecasts to 2023" report has been added to Research and Markets' offering. The global human vaccines market is projected to grow with a CAGR of 11.0% to 12.0% from 2017 to 2023 The high occurrence of various viral and bacterial diseases are driving the growth of the global human vaccines market. The intervention of governments as well as other non-governmental agencies through various awareness campaigns is aiding the increasing awareness about the benefits of human vaccines among the public worldwide. The increase in awareness is expected to enhance the growth of the human vaccines market, as it prompts more people to seek vaccinations. The compulsory and non-compulsory vaccination as part of immunisation programmes for children against certain diseases are expected to drive the growth of the global human vaccines market, as these vaccines are essential to prevent some of the eradicated diseases from re-emerging. Minimal or low occurrence of fatal or serious side effects related to human vaccines as per the age group, paediatric segment accounts for more than 50% of the overall human vaccines demand. Among the vaccine products, pneumococcal segment accounts for significant market share. Combination human vaccines are expected to attain considerable growth during the forecast period. As there are minimal or relatively low risk of seious or fatal side effects related to the human vaccines people are now more open to the use of vaccines. Moreover, the assurance from major health organisations such as WHO and AMA, drives the adoption of human vaccines significantly and it is expected to drive the growth of the global human vaccines market during the forecast period. Stringent regulations set by various countries and high costs associated with research and development, manufacturing, handling, storage and transportation are the major challenges for the major players in the global human vaccines market. The technical expertise and patents by a few players in the market are among the challenges for the new entrants in this market; moreover, it requires a huge investments for new players to enter the market. These are expected to remain as the major restraints for the global human vaccines market during the forecast period. Due to the intense competition, mergers and acquisitions are expected to be a pathway for major players for consolidation in the global human vaccines market during the forecast period. Opportunities are expected to be there for the major players to expand in the developing and poor economies as governments focus on immunisation programmes against various diseases during the forecast period. Companies Profiled: - CSL Limited, - GlaxoSmithKline PLC, - Merck & Co. Inc., - Novartis AG, - Pfizer Inc., - Takeda Pharmaceutical Company Limited., - Emergent BioSolutions Inc., - Bavarian Nordic, - Sanofi Pasteur - Serum Institute of India Pvt Ltd. Key Topics Covered: 1. Preface 2. Executive Summary 3. Global Human Vaccines Market Overview 4. Global Human Vaccines Market Analysis, by Product (USD Million, KT (News - Alert)) 2017-2023 5. Global Human Vaccines Market Analysis, by Disease Condition (USD Million, KT) 2017-2023 6. Global Human Vaccines Market Analysis, by Region (USD Million, KT) 2017-2023 7. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/thkbg4/human_vaccines
View source version on businesswire.com: http://www.businesswire.com/news/home/20171009005786/en/ |
